Ontology highlight
ABSTRACT: Background
Duration of viral shedding is a determinant of infectivity and transmissibility, but few data exist about oseltamivir's ability to alter viral shedding.Methods
From January 2012 through October 2017, a randomized, double-blinded multicenter clinical trial was conducted in adults aged 18-64 years at 42 sites in Thailand, the United States, and Argentina. Participants with influenza A or B and without risk factors for complications of influenza were screened for the study. Eligible participants were randomized to receive oseltamivir 75 mg or placebo twice daily for 5 days. The primary endpoint was the percentage of participants with virus detectable by polymerase chain reaction in nasopharyngeal swab at day 3.Results
Of 716 adults screened for the study, 55
SUBMITTER: Beigel JH
PROVIDER: S-EPMC7245154 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature